Get the Stockscreener App
0.6836
2.75%
-0.0193
Icecure Medical Ltd stock is traded at $0.6836, with a volume of 505.40K.
It is down -2.75% in the last 24 hours and down -5.59% over the past month.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
See More
Previous Close:
$0.7029
Open:
$0.6728
24h Volume:
505.40K
Relative Volume:
0.45
Market Cap:
$47.14M
Revenue:
$3.67M
Net Income/Loss:
$-13.83M
P/E Ratio:
-2.4414
EPS:
-0.28
Net Cash Flow:
$-10.79M
1W Performance:
-2.45%
1M Performance:
-5.59%
6M Performance:
-33.63%
1Y Performance:
-16.64%
1-Day Range:
$0.67
$0.71
1-Week Range:
$0.67
$0.7299
52-Week Range:
$0.59
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.6836 | 48.47M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Icecure Medical Ltd Stock (ICCM) Latest News
Why IceCure Medical Ltd stock remains on buy listsJuly 2025 Movers & Real-Time Volume Analysis Alerts - Newser
How IceCure Medical Ltd stock benefits from global expansionJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - Newser
IceCure Medical schedules special shareholder meeting for January 2026 By Investing.com - Investing.com Canada
IceCure Medical schedules special shareholder meeting for January 2026 - Investing.com
IceCure Medical Announces Special General Meeting for Key Votes - TipRanks
Why retail investors pile into IceCure Medical Ltd stockJuly 2025 Catalysts & Short-Term Swing Trade Alerts - BỘ NỘI VỤ
IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances (PR Newswire) - Aktiellt
Icecure Medical Ltd (ICCM) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period (PR Newswire) - Aktiellt
IceCure Medical Ltd (NASDAQ:ICCM) Q3 2025 Earnings Call Transcript - Insider Monkey
How IceCure Medical Ltd stock compares to market leadersJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Is IceCure Medical Ltd stock a bargain at current levels2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
IceCure Medical Reports Q3 2025 Financial Results - TipRanks
Is IceCure Medical Ltd a candidate for recovery playJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
IceCure Medical Ltd stock momentum explained2025 Year in Review & Verified Stock Trade Ideas - newser.com
Using Ichimoku Cloud for IceCure Medical Ltd technicals - newser.com
IceCure Medical’s Earnings Call Highlights Growth Potential - TipRanks
ICCM: FDA approval of ProSense drives growth prospects amid revenue decline and strong cash position - TradingView
Does IceCure Medical Ltd fit your quant trading modelJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com
IceCure Medical Q3 2025 Earnings Call Transcript - MarketBeat
IceCure Medical Gains FDA Approval for ProSense® in Breast Cancer Treatment - MSN
IceCure Medical Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025 - marketscreener.com
IceCure Medical Ltd. (ICCM) Q3 FY2025 earnings call transcript - Yahoo Finance
ICCM: FDA approval for ProSense® sets stage for accelerated growth despite lower 2025 revenue - TradingView
When is the best time to exit IceCure Medical LtdTrade Analysis Report & Fast Gain Stock Trading Tips - newser.com
IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025 - Eastern Progress
IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025 - Finviz
IceCure's ProSense Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer - Finviz
IceCure's ProSense® Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer - The Malaysian Reserve
Icecure Medical Ltd (ICCM) Q3 2025 Earnings Report Preview: What To Expect - GuruFocus
IceCure's ProSense® cryoablation system receives regulatory approval in Switzerland for indications including breast, lung, liver, and kidney cancer - MarketScreener
IceCure Medical receives Nasdaq minimum bid price notification - Medical Buyer
Why IceCure Medical Ltd stock attracts high net worth investors2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Market reaction to IceCure Medical Ltd’s recent newsRecession Risk & Scalable Portfolio Growth Ideas - newser.com
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price No - GuruFocus
IceCure Medical Receives Nasdaq Bid Price Notification - TipRanks
IceCure Medical announces receipt of Nasdaq minimum bid price notification - MarketScreener
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification - PR Newswire
Icecure Medical Ltd Stock (ICCM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):